Michael J Hageman

Title: The Innovative Contributions of Michael J Hageman

Introduction

Michael J Hageman is a notable inventor based in Portage, MI (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of cyclooxygenase-2 inhibitors. With a total of 3 patents to his name, Hageman's work has focused on enhancing the bioavailability and therapeutic effects of important medications.

Latest Patents

Hageman's latest patents include a solid-state form of celecoxib that boasts enhanced bioavailability. This innovative formulation presents celecoxib in an amorphous state, which is crucial for improving its effectiveness. Additionally, he has developed a celecoxib-crystallization inhibitor composite that combines amorphous celecoxib with crystallization inhibitors, such as polymers. This composite is designed to enhance the stability and efficacy of the drug. Furthermore, Hageman has created pharmaceutical compositions that allow for rapid onset of therapeutic effects, particularly beneficial for treating conditions mediated by cyclooxygenase-2.

Career Highlights

Throughout his career, Hageman has worked with prominent companies, including Pharmacia Corporation and Pfizer, Inc. His experience in these organizations has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry.

Collaborations

Hageman has collaborated with esteemed colleagues, including Tugrul T Kararli and Xiaorong He. These partnerships have further enriched his work and led to advancements in drug formulation and delivery.

Conclusion

Michael J Hageman's innovative contributions to the pharmaceutical field, particularly in the development of cyclooxygenase-2 inhibitors, have made a significant impact on medical treatments. His patents reflect a commitment to improving drug efficacy and patient outcomes.